<DOC>
	<DOCNO>NCT02095691</DOCNO>
	<brief_summary>This prospective , multi-center , non-randomized , feasibility study assess safety effectiveness renal artery sympathetic denervation use investigational device subject resistant hypertension .</brief_summary>
	<brief_title>RENABLATE-II Feasibility Study Catheter Based Renal Denervation Treat Resistant Hypertension - 157</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Renal</mesh_term>
	<criteria>1 . Subject systolic blood pressure â‰¥ 140 mmHg base average 3 office blood pressure reading measure accord BP guideline . 2 . Subject adhere stable drug regimen least 3 different class antihypertensive medication , include diuretic ( change minimum 2 week prior enrollment ) optimal dose expect maintain least 6 month . 3 . Subject &gt; 18 &lt; 85 year age . 4 . Subject agree study procedure perform , competent willing provide write , inform consent participate study . Key 1 . A secondary cause hypertension , e.g . `` white coat '' hypertension ( assessed 24 h ABPM physician 's discretion ) , primary aldosteronism , pheochromocytoma , renal artery stenosis , drug inducedhypertension , Adult Polycystic kidney Disease , renal cell carcinoma , pyelonephritis , glomerulonephritis , coarctation aorta , acromegaly , Cushing 's Syndrome , Conn 's ( primary hyperaldosteronism ) , polyarteritis nodosum , systemic sclerosis , parenchymal kidney disease , obstructive sleep apnoea base workup perform within 12 month precede enrollment . 2 . Subject aortoiliofemoral artery anatomy suitable treatment investigational device ( ) . 3 . Subject main renal artery &lt; 20 mm length &lt; 4 mm diameter . 4 . Subject prior history renal artery intervention include limited balloon angioplasty , stenting , renal denervation surgery . 5 . Subject estimate glomerular filtration rate ( eGFR ) &lt; 45mL/min/1.73m2 , use MDRD formula . 6 . Subject type 1 diabetes mellitus . 7 . Subject history Myocardial Infarction , unstable angina pectoris , cerebrovascular accident 6 month period prior enrolment , documented widespread atherosclerosis , intravascular thrombosis unstable plaque . 8 . Subject hemodynamically significant valvular heart disease reduction blood pressure would consider hazardous .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Renal Sympathetic Denervation</keyword>
</DOC>